Immunogenicity and escape mechanisms of allogeneic tendon-derived stem cells

Tissue Engineering - Part A

Volumn 20, Issue 21-22, 2014, Pages 3010-3020

  Lui, Pauline Po Yee ^a   Kong, Siu Kai ^b   Lau, Pui Man ^b   Wong, Yin Mei ^c   Lee, Yuk Wa ^c   Tan, Chunlai ^c   Wong, On Tik ^c  

^a HOSPITAL AUTHORITY   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROLIFERATION; CYTOTOXICITY; STEM CELLS; T-CELLS;

ANTIBODY RECOGNITION; COMPLEMENT-DEPENDENT CYTOTOXICITIES; INDOLEAMINE 2 ,3-DIOXYGENASE; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MECHANISTIC STUDIES; PHORBOL 12 MYRISTATE 13 ACETATES; TRANSFORMING GROWTH FACTOR BETA;

TENDONS;

INDOLEAMINE 2,3 DIOXYGENASE; PHORBOL 13 ACETATE 12 MYRISTATE; TRANSFORMING GROWTH FACTOR BETA1; TRITON X 100; CYTOKINE;

ALLOGENEIC STEM CELL TRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MEDIATED CYTOTOXICITY; CELL PROLIFERATION; CELL SELECTION; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; IMMUNE RESPONSE; IMMUNOGENICITY; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR RECOGNITION; NONHUMAN; RAT; SPLEEN WEIGHT; STEM CELL; STEM CELL TRANSPLANTATION; TENDON; TENDON DERIVED STEM CELL; UPREGULATION; ALLOTRANSPLANTATION; ANIMAL; CELL CULTURE; IMMUNOLOGY; INJURIES; LYMPHOCYTE; MALE; PATELLA LIGAMENT; PATHOLOGY; PROCEDURES; SPRAGUE DAWLEY RAT; TENDON INJURIES;

ANIMALS; CELLS, CULTURED; CYTOKINES; LYMPHOCYTES; MALE; PATELLAR LIGAMENT; RATS; RATS, SPRAGUE-DAWLEY; TENDON INJURIES; TRANSPLANTATION, HOMOLOGOUS;

EID: 84909945509     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2013.0714     Document Type: Article

References (36)

1. Aggarwal, S., and Pittenger, M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105, 1815, 2005.
2. Zappia, E., Casazza, S., Pedemonte, E., Benvenuto, F., Bo-nanni, I., Gerdoni, E., Giunti, D., Ceravolo, A., Cazzanti, F., Frassoni, F., Mancardi, G., and Uccelli, A. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106, 1755, 2005.
3. Avanzini, M.A., Bernardo, M.E., Cometa, A.M., Perotti, C., Zaffaroni, N. Novara, F., Visai, L., Moretta, A., Fante, C.D., Villa, R., Ball, L.M., Fibbe, W.E., Maccario, R., and Locatelli, F. Generation of mesenchymal stromal cells in the presence of platelet lysate: a phenotypic and functional comparison of umbilical cord blood-and bone marrow-derived progenitors. Haematologica 94, 1649, 2009.
4. Bartholomew, A., Sturgeon, C., Siatska, M., Ferrer, K., McIntosh, K., Patil, S., Hardy, W., Devine, S., Ucker, D., Deans, R., Moseley, A., and Hoffman, R. Mesenchymal stem cells suppress lympohocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30, 42, 2002.
5. Di Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P.D., Matteucci, P., Grisanti, S., and Gianni, A.M. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or non-specific mitogenic stimuli. Blood 99, 3838, 2002.
6. Le Blanc, K., Tammik, L., Sundberg, B., Haynesworth, S.E., and Ringden, O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand J Immunol 57, 11, 2003.
7. Majumdar, M.K., Keane-Moore, M., Buyaner, D., Hardy, W.B., Moorman, M.A., McIntosh, K.R., and Mosca, J.D. Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J Biomed Sci 10, 228, 2003.
8. Mcintosh, K., Zvonic, S., Garrett, S., Mitchell, J.B., Floyd, Z.E., Hammill, L., Kloster, A., Halvorsen, Y.D., Ting, J.P., Storms, R.W., Goh, B., Kilroy, G., Wu, X., and Gimble, J.M. The immunogenicity of human adipose-derived cells: temporal changes in vitro. Stem Cells 24, 1246, 2006.
9. Puissant, B., Barreau, C., Bourin, P., Clavel, C., Corre, J., Bousquet, C., Taureau, C., Cousin, B., Abbal, M., La-harrague, P., Penicaud, L., Casteilla, L., and Blancher, A. Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesen-chymal stem cells. Br J Haematol 129, 118, 2005.
10. Wang, M., Yang, Y., Yang, D., Luo, F., Liang, W., Guo, S., and Xu, J. The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro. Immunology 126, 220, 2009.
11. Ryan, J.M., Barry, F.P., Murphy, J.M., and Mahon, B.P. Mesenchymal stem cells avoid allogeneic rejection. J In-flamm (Lond) 2, 8, 2005.
12. Rui, Y.F., Lui, P.P.Y., Li, G., Fu, S.C., Lee, Y.W., and Chan, K.M. Isolation and characterization of multi-potent rat tendon-derived stem cells. Tissue Eng Part A 16, 1549, 2010.
13. Ni, M., Lui, P.P.Y., Rui, Y.F., Lee, Y.W., Tan, Q., Wong, Y.M., Kong, S.K., Lau, P.M., Li, G., and Chan, K.M. Tendon-derived stem cells (TDSCs) promote tendon repair in a rat patellar tendon window defect model. J Orthop Res 30, 613, 2012.
14. Ding, R., Tang, J., Gao, H., Li, T., Zhou, H., Liu, L., and Yao, X.S. New methymycin derivatives of Streptomyces venezuelae ATCC 15439 and their inhibitory effects on human T cell proliferation mediated by PMA/ionomycin. Arch Pharm Res 35, 1567, 2012.
15. Ye, Y., Zhang, Y., Lu, X., Huang, X., Zeng, X., Lai, X., and Zeng, Y. The anti-inflammatory effect of the SOCC blocker SK&F 96365 on mouse lymphocytes after stimulation by ConA or PMA/ionomycin. Immunobiology 216, 1044, 2011.
16. Gao, K., Chen, Y., Wei, L., Li, S., Jin, X., Cong, C., Yuan, Y., Long, D., Li, Y., Cheng, J., and Lu, Y. Inhibitory effect of mesenchymal stem cells on lymphocyte proliferation. Cell Biochem Funct 26, 900, 2008.
17. Geroge, J.F., Sweeney, S.D., Kirklin, J.K., Simpson, E.M., Goldstein, D.R., and Thomas, J.M. An essential role for Fas ligand in transplantation tolerance induced by donor bone marrow. Nat Med 4, 333, 1998.
18. Liu, J., Lu, X.F., Wan, L., Li, Y.P., Li, S.F., Zeng, L.Y., Zeng, Y.Z., Cheng, L.H., Lu, Y.R., and Cheng, J.Q. Suppression of human peripheral blood lymphocyte proliferation by immortalized mesenchymal stem cells derived from bone marrow of Banna Minipig inbred-line. Transplant Proc 36, 3272, 2004.
19. Mazar, J., Thomas, M., Bezrukov, L., Chanturia, A., Pek-kurnaz, G., Yin, S., Kuznetsov, S.A., Robey, P.G., and Zimmerberg, J. Cytotoxicity mediated by the Fas ligand (FasL)-activated apoptotic pathway in stem cells. J Bio Chem 284, 22022, 2009.
20. Holan, V., Pokorna, K., Prochazkova, J., Krulova, M., and Zajicova, A. Immunoregulatory properties of mouse limbal stem cells. J Immunol 184, 2124, 2010.
21. Knight, J.C., Scharf, E.L., and Mao-Draayer, Y. Fas activation increases neural progenitor cell survival. J Neurosci Res 88, 746, 2010.
22. Liu, H., Kemeny, D.M., Heng, B.C., Ouyang, H.W., Melendez, A.J., and Cao, T. The immunogenicity and im-munomodulatory function of osteogenic cells differentiated from mesenchymal stem cells. J Immunol 176, 2864, 2006.
23. Zhang, X., Tang, T., Shi, Q., Fernandes, J.C., and Dai, K. The immunologic properties of undifferentiated and osteogenic differentiated mouse mesenchymal stem cells and its potential application in bone regeneration. Immunobiology 214, 179, 2009.
24. Corcione, A., Benvenuto, F., Ferretti, E., Giunti, D., Cap-piello, V., Cazzanti, F., Risso, M., Gualandi, F., Mancardi, G.L., Pistoia, V., and Uccelli, A. Human mesenchymal stem cells modulate B-cell functions. Blood 107, 367, 2006.
25. Isa, A., Nehlin, J.O., Sabir, H.J., Andersen, T.E., Gaster, M., Kassem, M., and Barington, T. Impaired cell surface expression of HLA-B antigens on mesenchymal stem cells and muscle cell progenitors. PLoS One 5, e10900, 2010.
26. Tu, Z., Li, Q., Bu, H., and Lin, F. Mesenchymal stem cells inhibit complement activation by secreting factor. Stem Cells Dev 19, 1803, 2010.
27. Glennie, S., Soeiro, I., Dyson, P.J., Lam, E.W., and Dazzi, F. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 105, 2821, 2005.
28. Beyth, S., Borovsky, Z., Mevorach, D., Liebergall, M., Gazit, Z., Aslan, H., Galun, E., and Rachmilewitz, J. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105, 2214, 2005.
29. Rasmusson, I., Ringden, O., Sundgerg, B., and Le Blanc, K. Mesenchymal stem cells inhibit the formation of cy-totoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 76, 1208, 2003.
30. Smelt, M.J., de Haan, B.J., Bron, P.A., van Swam, I., Meijerink, M., Wells, J.M., Kleerebezem, M., Faas, M.M., and de Vos, P. The impact of lactobacillus plan-tarum WCFS1 teichoic acid D-alanylation on the generation of effector and regulatory T-cells in health mice. PLoS One 8, e63099, 2013.
31. Le Blanc, K., Tammik, C., Rosendahl, K., Zetterberg, E., and Ringden, O. HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 31, 890, 2003.
32. Tse, W.T., Pendleton, J.D., Beyer, W., Tgalka, M.C., and Guinan, E.C. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 75, 389, 2003.
33. Ruggeri, L., Capanni, M., Martelli, M.F., and Velardi, A. Cellular therapy: exploiting NK cell alloreactivity in transplantation. Curr Opin Hematol 8, 355, 2001.
34. English, K., Barry, F.P., Field-Corbett, C.P., and Mahon, B.P. IFN-gamma and TNF-alpha differentially regulate immunomodulation by murine mesenchymal stem cells. Immunol Lett 110, 91, 2007.
35. Ryan, J.M., Barry, F., Murphy, J.M., and Mahon, B.P. Interferon-gamma does not break, but promotes the im-munosuppressive capacity of adult human mesenchymal stem cells. Clin Exp Immunol 149, 353, 2007.
36. Meisel, R., Zibert, A., Laryea, M., Gobel, U., Daubener, W., and Dilloo, D. Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2, 3-dioxygenase-mediated tryptophan degradation. Blood 103, 4619, 2004.